Literature DB >> 2208666

Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel.

L M Shaw1, R W Yatscoff, L D Bowers, D J Freeman, J R Jeffery, P A Keown, I J McGilveray, T G Rosano, P Y Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2208666

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  13 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Cyclosporine monitoring: consensus recommendations and guidelines. Canadian Consensus Meeting on Cyclosporine Monitoring.

Authors:  R W Yatscoff
Journal:  CMAJ       Date:  1991-05-01       Impact factor: 8.262

3.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

Review 4.  Target concentration strategy for cyclosporin monitoring.

Authors:  R G Morris
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

Review 5.  Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors:  María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Synthesis, maturation, and trafficking of human Na+-dicarboxylate cotransporter NaDC1 requires the chaperone activity of cyclophilin B.

Authors:  Marc J Bergeron; Marc Bürzle; Gergely Kovacs; Alexandre Simonin; Matthias A Hediger
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

7.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

Review 8.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 9.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

10.  Effect of cyclosporine in a murine model of experimental colitis.

Authors:  Marko Banić; Branimir Anić; Tomislav Brkić; Neven Ljubicić; Sanja Plesko; Csaba Dohoczky; Damir Erceg; Mladen Petrovecki; Igor Stipancić; Ivo Rotkvić
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.